HK1013315A1 - Novel polypeptide having factor xa inhibitory activity - Google Patents
Novel polypeptide having factor xa inhibitory activityInfo
- Publication number
- HK1013315A1 HK1013315A1 HK98114597A HK98114597A HK1013315A1 HK 1013315 A1 HK1013315 A1 HK 1013315A1 HK 98114597 A HK98114597 A HK 98114597A HK 98114597 A HK98114597 A HK 98114597A HK 1013315 A1 HK1013315 A1 HK 1013315A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- polypeptide
- factor
- novel polypeptide
- inhibitory activity
- deposited
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A61K38/58—Protease inhibitors from animals; from humans from leeches, e.g. hirudin, eglin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4580593A | 1993-04-09 | 1993-04-09 | |
| PCT/US1994/003871 WO1994023735A1 (en) | 1993-04-09 | 1994-04-08 | Novel polypeptide having factor xa inhibitory activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1013315A1 true HK1013315A1 (en) | 1999-08-20 |
Family
ID=21939985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK98114597A HK1013315A1 (en) | 1993-04-09 | 1998-12-22 | Novel polypeptide having factor xa inhibitory activity |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0696198B1 (xx) |
| JP (1) | JPH08511157A (xx) |
| KR (1) | KR960701649A (xx) |
| AT (1) | ATE198710T1 (xx) |
| AU (1) | AU682361B2 (xx) |
| CA (1) | CA2159218A1 (xx) |
| DE (1) | DE69426598T2 (xx) |
| DK (1) | DK0696198T3 (xx) |
| ES (1) | ES2155472T3 (xx) |
| GR (1) | GR3035722T3 (xx) |
| HK (1) | HK1013315A1 (xx) |
| IL (1) | IL109259A0 (xx) |
| NZ (1) | NZ265507A (xx) |
| PT (1) | PT696198E (xx) |
| WO (1) | WO1994023735A1 (xx) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2338665C (en) | 1998-08-06 | 2011-01-18 | Mountain View Pharmaceuticals, Inc. | Peg-urate oxidase conjugates and use thereof |
| ES2856881T3 (es) | 2005-04-11 | 2021-09-28 | Horizon Pharma Rheumatology Llc | Formas variantes de urato oxidasa y su uso |
| EP1871877A2 (en) | 2005-04-11 | 2008-01-02 | Savient Pharmaceuticals, Inc. | A variant form of urate oxidase and use thereof |
| US8148123B2 (en) | 2005-04-11 | 2012-04-03 | Savient Pharmaceuticals, Inc. | Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
| ES2532804T3 (es) | 2006-04-12 | 2015-03-31 | Crealta Pharmaceuticals Llc | Purificación de proteínas con tensioactivo catiónico |
| AU2010265964B2 (en) | 2009-06-25 | 2014-09-18 | Horizon Therapeutics Usa, Inc. | Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during PEGylated uricase therapy |
| US8784896B2 (en) | 2012-09-17 | 2014-07-22 | Biopep Solutions, Inc | Antioxidant therapy with a whole, leech saliva extract |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4588587A (en) * | 1983-03-01 | 1986-05-13 | Pennsylvania Hospital | Method of treatment to inhibit metastasis |
| DE58907266T2 (de) * | 1988-06-11 | 1994-09-29 | Ciba Geigy Ag | Polypeptide mit einer die Koagulierung hemmenden Wirkung. |
| US4832849A (en) * | 1988-06-16 | 1989-05-23 | Merrell Dow Pharmaceuticals Inc. | Extraction and purification of an anticoagulant principle from the south american leech, haementeria ghilianii |
| IL86856A0 (en) * | 1988-06-24 | 1988-11-30 | Yissum Res Dev Co | Bovine xa factor and pharmaceutical compositions containing the same |
-
1994
- 1994-04-08 WO PCT/US1994/003871 patent/WO1994023735A1/en active IP Right Grant
- 1994-04-08 PT PT94914087T patent/PT696198E/pt unknown
- 1994-04-08 CA CA002159218A patent/CA2159218A1/en not_active Abandoned
- 1994-04-08 KR KR1019950704404A patent/KR960701649A/ko active IP Right Grant
- 1994-04-08 DK DK94914087T patent/DK0696198T3/da active
- 1994-04-08 JP JP6523326A patent/JPH08511157A/ja not_active Ceased
- 1994-04-08 AU AU66291/94A patent/AU682361B2/en not_active Ceased
- 1994-04-08 NZ NZ265507A patent/NZ265507A/en unknown
- 1994-04-08 IL IL10925994A patent/IL109259A0/xx unknown
- 1994-04-08 ES ES94914087T patent/ES2155472T3/es not_active Expired - Lifetime
- 1994-04-08 DE DE69426598T patent/DE69426598T2/de not_active Expired - Fee Related
- 1994-04-08 AT AT94914087T patent/ATE198710T1/de not_active IP Right Cessation
- 1994-04-08 EP EP94914087A patent/EP0696198B1/en not_active Expired - Lifetime
-
1998
- 1998-12-22 HK HK98114597A patent/HK1013315A1/xx not_active IP Right Cessation
-
2001
- 2001-04-06 GR GR20010400573T patent/GR3035722T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH08511157A (ja) | 1996-11-26 |
| KR960701649A (ko) | 1996-03-28 |
| EP0696198A4 (en) | 1999-01-27 |
| AU682361B2 (en) | 1997-10-02 |
| DE69426598T2 (de) | 2001-08-09 |
| EP0696198B1 (en) | 2001-01-17 |
| WO1994023735A1 (en) | 1994-10-27 |
| NZ265507A (en) | 1998-09-24 |
| AU6629194A (en) | 1994-11-08 |
| CA2159218A1 (en) | 1994-10-27 |
| EP0696198A1 (en) | 1996-02-14 |
| ES2155472T3 (es) | 2001-05-16 |
| DK0696198T3 (da) | 2001-08-06 |
| IL109259A0 (en) | 1994-07-31 |
| DE69426598D1 (de) | 2001-02-22 |
| ATE198710T1 (de) | 2001-02-15 |
| PT696198E (pt) | 2001-07-31 |
| GR3035722T3 (en) | 2001-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3026263T3 (en) | Epithelins: novel cysteine - rich growth modulating proteins | |
| NZ233451A (en) | Production of vascular endothelial growth factor and dna encoding same | |
| PL309398A1 (en) | Interferon containing therapeutic composition | |
| GR3035722T3 (en) | Novel polypeptide having factor xa inhibitory activity | |
| PT86381A (en) | Molecular cloning and expression of human il-3 | |
| AU1609992A (en) | Novel bacteriocin from lactococcus lactis subspecies lactis | |
| PL307258A1 (en) | Peptides capable to block calcium canals with agelenopsis aperta | |
| TW327627B (en) | Water purification material, process of preparation thereof and water purification unit | |
| EP0460072A4 (en) | Human elastase inhibitor | |
| CA2093819A1 (en) | Platelet adhesion inhibitor | |
| CA2017315A1 (en) | Interleukin i inhibitor | |
| DE59302129D1 (de) | Verwendung von bärlauch zur therapie oder prophylaxe von herzrhythmusstörungen | |
| CA2004202A1 (en) | Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon | |
| Lekan | CORONA TREATMENT AS AN ADHESION PROMOTER FOR UV-/EB-CURABLE COATINGS | |
| EP0181524A3 (en) | Novel lymphokine | |
| UA7184C2 (uk) | Контактний спосіб зниження артеріального тиску за методикою шпортюк м.і. | |
| Rawczynska-Englert et al. | Staphylococcal endocarditis after valve replacement(9 years of experience). |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20050408 |